The effect of age on the acquisition and selection of cancer driver mutations in sun-exposed normal skin.


Journal

Annals of oncology : official journal of the European Society for Medical Oncology
ISSN: 1569-8041
Titre abrégé: Ann Oncol
Pays: England
ID NLM: 9007735

Informations de publication

Date de publication:
03 2021
Historique:
received: 09 07 2020
revised: 18 11 2020
accepted: 29 11 2020
pubmed: 12 12 2020
medline: 6 3 2021
entrez: 11 12 2020
Statut: ppublish

Résumé

The accumulation of somatic mutations contributes to ageing and cancer. Sunlight is the principal aetiological factor associated with skin cancer development. However, genetic and phenotypic factors also contribute to skin cancer risk. This study aimed at exploring the role of photoaging, as well as other well-known epidemiological risk factors, in the accumulation of somatic mutations in cancer-free human epidermis. We deeply sequenced 46 genes in normal skin biopsies from 123 healthy donors, from which phenotypic data (including age, pigmentation-related genotype and phenotype) and sun exposure habits were collected. We determined the somatic mutational burden, mutational signatures, clonal selection and frequency of driver mutations in all samples. Our results reveal an exponential accumulation of UV-related somatic mutations with age, matching skin cancer incidence. The increase of mutational burden is in turn modified by an individual's skin phototype. Somatic mutations preferentially accumulated in cutaneous squamous cell carcinoma cancer genes and clonally expanded with age, with distinct mutational processes underpinning different age groups. Our results suggest a loss of fidelity in transcription-coupled repair later in life. Our findings reveal that ageing is not only associated with an exponential increase in the number of somatic mutations accumulated in normal epidermis, but also with selection and expansion of cancer-associated mutations. Aged, sun-exposed normal skin is thus an extended mosaic of multiple clones with driver mutations, poised for the acquisition of transforming events.

Sections du résumé

BACKGROUND
The accumulation of somatic mutations contributes to ageing and cancer. Sunlight is the principal aetiological factor associated with skin cancer development. However, genetic and phenotypic factors also contribute to skin cancer risk. This study aimed at exploring the role of photoaging, as well as other well-known epidemiological risk factors, in the accumulation of somatic mutations in cancer-free human epidermis.
MATERIAL AND METHODS
We deeply sequenced 46 genes in normal skin biopsies from 123 healthy donors, from which phenotypic data (including age, pigmentation-related genotype and phenotype) and sun exposure habits were collected. We determined the somatic mutational burden, mutational signatures, clonal selection and frequency of driver mutations in all samples.
RESULTS
Our results reveal an exponential accumulation of UV-related somatic mutations with age, matching skin cancer incidence. The increase of mutational burden is in turn modified by an individual's skin phototype. Somatic mutations preferentially accumulated in cutaneous squamous cell carcinoma cancer genes and clonally expanded with age, with distinct mutational processes underpinning different age groups. Our results suggest a loss of fidelity in transcription-coupled repair later in life.
CONCLUSION
Our findings reveal that ageing is not only associated with an exponential increase in the number of somatic mutations accumulated in normal epidermis, but also with selection and expansion of cancer-associated mutations. Aged, sun-exposed normal skin is thus an extended mosaic of multiple clones with driver mutations, poised for the acquisition of transforming events.

Identifiants

pubmed: 33307203
pii: S0923-7534(20)43199-0
doi: 10.1016/j.annonc.2020.11.023
pmc: PMC7614988
mid: EMS185034
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

412-421

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 211179
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A23896
Pays : United Kingdom

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Disclosure NM has received consultancy fees and has stock options in Achilles Therapeutics. All remaining authors have declared no conflicts of interest. Data sharing Sequencing data have been deposited at the European Genome–phenome Archive (EGA) under the accession code EGAS00001004279. The somatic mutations found in all samples are listed in the Supplementary Dataset S1, available at https://doi.org/10.1016/j.annonc.2020.11.023. Clinical data of each donor can be found in the Supplementary Dataset S2, available at https://doi.org/10.1016/j.annonc.2020.11.023. Any other relevant data can be obtained from the corresponding authors upon reasonable request.

Références

Science. 2020 Mar 27;367(6485):1449-1454
pubmed: 32217721
Nature. 2019 Oct;574(7779):532-537
pubmed: 31645730
Science. 2018 Nov 23;362(6417):911-917
pubmed: 30337457
Science. 2015 May 22;348(6237):880-6
pubmed: 25999502
Nat Commun. 2018 Sep 10;9(1):3667
pubmed: 30202019
Nature. 2020 Feb;578(7793):94-101
pubmed: 32025018
Anticancer Res. 2018 Feb;38(2):1159-1164
pubmed: 29374753
Nature. 2005 Aug 4;436(7051):660-5
pubmed: 16079837
N Engl J Med. 2014 Dec 25;371(26):2488-98
pubmed: 25426837
Genome Biol. 2016 Feb 22;17:31
pubmed: 26899170
Cell. 2017 Nov 16;171(5):1029-1041.e21
pubmed: 29056346
Eur J Cancer. 2005 Jan;41(1):45-60
pubmed: 15617990
J Photochem Photobiol B. 2001 Oct;63(1-3):88-102
pubmed: 11684456
Nature. 2019 Oct;574(7779):538-542
pubmed: 31645727
Arch Dermatol. 2002 Nov;138(11):1462-70
pubmed: 12437452
Genome Med. 2019 May 28;11(1):35
pubmed: 31138277
Nucleic Acids Res. 2007;35(22):7466-74
pubmed: 17913742
Oncogene. 2003 May 19;22(20):3063-9
pubmed: 12789281
Mutat Res. 2010 Oct;705(2):141-153
pubmed: 20601102
Pigment Cell Res. 2002 Aug;15(4):242-50
pubmed: 12100489
J Invest Dermatol. 2003 Dec;121(6):1440-6
pubmed: 14675195
Nature. 2009 Apr 9;458(7239):719-24
pubmed: 19360079
Stem Cells Int. 2016;2016:7370642
pubmed: 27148370
Nature. 2005 Aug 4;436(7051):642
pubmed: 16079833
Nat Commun. 2016 Jul 12;7:12064
pubmed: 27403562
Clin Cancer Res. 2014 Dec 15;20(24):6582-92
pubmed: 25303977
Science. 2015 Sep 25;349(6255):1483-9
pubmed: 26404825
Photochem Photobiol. 2008 May-Jun;84(3):539-49
pubmed: 18435612
Pigment Cell Melanoma Res. 2014 Sep;27(5):699-720
pubmed: 24807163
Adv Exp Med Biol. 2014;810:120-40
pubmed: 25207363
J Invest Dermatol. 2004 Jun;122(6):1448-55
pubmed: 15175036
Trends Cancer. 2016 Oct;2(10):552-560
pubmed: 28439564
Science. 2019 Jun 07;364(6444):
pubmed: 31171663
Nature. 2017 May 11;545(7653):175-180
pubmed: 28467829
Cell Rep. 2018 Aug 14;24(7):1777-1789
pubmed: 30110635

Auteurs

B Hernando (B)

Department of Medicine, Jaume I University of Castellon, Castellon, Spain.

M Dietzen (M)

Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, UK.

G Parra (G)

Centre Nacional d'Anàlisi Genòmica-Centre de Regulació Genòmica (CNAG-CRG), Barcelona, Spain.

M Gil-Barrachina (M)

Department of Medicine, Jaume I University of Castellon, Castellon, Spain.

G Pitarch (G)

Department of Dermatology, Castellon University General Hospital, Castellon, Spain.

L Mahiques (L)

Department of Dermatology, Castellon University General Hospital, Castellon, Spain.

F Valcuende-Cavero (F)

Department of Dermatology, La Plana University Hospital, Villarreal, Spain.

N McGranahan (N)

Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, UK. Electronic address: nicholas.mcgranahan.10@ucl.ac.uk.

C Martinez-Cadenas (C)

Department of Medicine, Jaume I University of Castellon, Castellon, Spain. Electronic address: ccadenas@uji.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH